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Abstract: Sepsis, the clinical manifestation of serious infection, may disturb normal brain
development, especially in preterm infants with an immature brain. We hypothesized that neonatal
sepsis induces systemic metabolic alterations that rapidly affect metabolic signatures in immature
brain and cerebrospinal fluid (CSF). Cesarean-delivered preterm pigs systemically received 109
CFU/kg Staphylococcus epidermidis (SE) and were provided total parenteral nutrition (n = 9) or enteral
supplementation with bovine colostrum (n = 10) and compared with uninfected pigs receiving
parenteral nutrition (n = 7). Plasma, CSF, and brain tissue samples were collected after 24 h and
analyzed by 1H NMR-based metabolomics. Both plasma and CSF metabolomes revealed SE-induced
changes in metabolite levels that reflected a modified energy metabolism. Hence, increased plasma
lactate, alanine, and succinate levels, as well as CSF lactate levels, were observed during SE infection
(all p < 0.05, ANOVA analysis). Myo-inositol, a glucose derivative known for beneficial effects on lung
maturation in preterm infants, was also increased in plasma and CSF following SE infection. Enteral
colostrum supplementation attenuated the lactate accumulation in blood and CSF. Bloodstream
infection in preterm newborns was found to induce a rapid metabolic shift in both plasma and CSF,
which was modulated by colostrum feeding.
Keywords: NMR metabolomics; neonatal sepsis; preterm infants; bloodstream infection;
cerebrospinal fluid; Staphylococcus epidermidis; brain metabolites; cerebral metabolism; enteral feeding;
bioactive dairy components
1. Introduction
Sepsis, the clinical manifestation of an uncontrolled bloodstream infection (BSI), is a frequent cause
of morbidity and mortality in newborns, especially in preterm infants with very low birth weight [1].
Coagulase-negative staphylococci are among the most frequent pathogens in neonatal sepsis,
particularly Staphylococcus epidermidis (SE), which is often acquired from the hospital environment
through invasive medical devices [2]. Preterm infants born at a lower gestational age are most
susceptible to hospital-acquired infections and life-threatening sepsis due to their immature innate
immune system and limited maternal passive immunity [3].
In recent decades, the incidence of neonatal sepsis related to hospital-acquired infections has
increased together with improved survival of the majority of preterm infants due to advances
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in medical care [1,4,5]. Nevertheless, neonatal sepsis increases the risk of brain injury and
neurodevelopmental impairment [6,7]. An elevated level of proinflammatory cytokines, as part
of the infection-related inflammatory response, is neurotoxic and increases the permeability of
the blood–brain barrier and may cause neurodevelopmental impairments [8,9]. Thus, exposure
to neonatal systemic infection leads to central nervous system (CNS) inflammation, potentially causing
brain injury with long-lasting consequences for neurological and mental health [6,10]. It remains
unclear if the infection-induced systemic inflammatory reactions are also associated with rapid
metabolic perturbations in the cerebrospinal fluid (CSF) and the immature brain. It has been shown
that endogenous metabolites, such as succinate and itaconate, may play separate roles to regulate
inflammatory responses [11,12]. In addition, increases in the intracellular glycerophosphoinositol level
of macrophages can be observed in lipopolysaccharide-induced inflammation, probably reflecting a
modulatory effect on inflammatory responses [13]. Systemic metabolic adaptations during neonatal
sepsis have been demonstrated [14] but the effect on cerebral energy metabolism is less known, though
it may be of importance.
Diminishing BSI and systemic inflammation may reduce the risk of brain injury and improve
long-term outcomes in preterm infants [8,9]. Human milk feeding decreases the risk of sepsis in preterm
infants [15]. Colostrum, the first milk of mammals, contains a multitude of anti-inflammatory and
anti-microbial proteins and peptides, known to protect the immature intestine of preterm infants from
opportunistic enteric bacteria and the development of necrotizing enterocolitis (NEC) [16–21]. Whether
colostrum feeding can also ameliorate systemic inflammation and protect against BSI and the associated
metabolic effects in preterm infants remains to be clarified. Using a clinically relevant BSI model
in preterm pigs, we previously showed that SE inoculation caused a severe inflammatory response
in CSF and plasma and that enteral colostrum supplementation reduced sepsis incidence and brain
inflammation [16]. Building further on these initial findings, we hypothesized that SE infection induces
metabolic perturbations in the immature brain and CSF, which may relate to perturbations in blood
plasma. Thus, we investigated if neonatal BSI changes the plasma, CSF, and brain tissue metabolomes
as part of the inflammatory response and if early colostrum feeding modulates the metabolome.
Metabolomics is a relevant tool to describe the metabolic perturbations and adaptations in body fluids
which accompany infection and inflammation [22–24]. Thus, 1H-NMR and high-resolution magic-angle
spinning (HR-MAS) NMR spectroscopic analyses were adopted to profile the metabolomes of CSF,
plasma, and brain.
2. Materials and Methods
2.1. Animal Experimental Procedures
Twenty-six pigs from two sows (Danish landrace × Large White × Duroc) were delivered by
cesarean section at 90% gestation. Shortly after birth, animals were transferred to individual preheated
(37 ◦C) incubators with oxygen supply (1–2 L/min) and fitted with umbilical arterial catheters and
orogastric feeding tubes. The pigs were stratified by sex and birth weight and randomly allocated to
one of three groups: (i) a control group receiving intra-arterial saline and 6 mL/kg/h total parenteral
nutrition, TPN (CON + TPN, n = 7), (ii) an infected group receiving SE inoculation (1.0 × 109 CFU/kg
body weight) and 6 mL/kg/h TPN (SE + TPN, n = 9), or (iii) a colostrum supplementation group
receiving the same dose of SE and 3 mL/kg/h supplementary parenteral nutrition + 10 mL/kg/3 h
bovine colostrum (SE + COL, n = 10). The bovine colostrum (Biofiber-Damino, Gesten, Denmark)
was produced from the first and second milkings within 24 h after the parturition of Danish Holstein
dairy cattle, Holder-pasteurized and spray-dried before use. Animals were administered SE or
saline by a 3-min continuous intra-arterial infusion within 4 h after birth. Detailed descriptions of
nutritional compositions of colostrum and parenteral formulation and preparation of the SE inoculate
are available elsewhere [25,26]. Twenty-four hours after SE administration, a mixed blood sample
was collected by intracardial puncture to obtain plasma, and piglets were subsequently euthanized
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with a lethal intracardial injection of barbiturate. CSF was collected by suboccipital puncture and
the brains were gently collected. Six brain structures of interest (cerebellum, periventricular white
matter (PVMW), striatum, hypothalamus, prefrontal cortex, and midbrain) were dissected and stored
at −80 ◦C until analysis. In order to investigate the correlation between the acquired metabolomics
data and neuroinflammation, we re-analyzed previously published cerebral immune cell staining
and hippocampus gene expression data obtained from the same animals as the present metabolomics
study. A detailed description of the methodologies as well as the 24-h survival rate can be found
elsewhere [25]. The animal procedures were all approved by the Danish National Committee on
Animal Experimentation (2014-15-0201-00418).
2.2. NMR Sample Preparation
2.2.1. Liquid 1H NMR Spectroscopy
Thawed plasma samples were filtered using Amicon Ultra 0.5-mL 3 kDa (Millipore, Billerica, MA,
USA) and spin filtering at 10,000 × g at 4 ◦C for 3 h to remove the lipid and proteins. No filtration
was performed on the CSF samples. A mixture of 100 µL CSF sample, 490 µL D2O, and 10 µL D2O
containing 0.05% sodium trimethylsilyl-[2,2,3,3-2H4]-1-propionate (TSP; Sigma-Aldrich, St. Louis,
MO, USA) as an internal chemical shift reference was transferred to a 5-mm NMR tube (Wilmad,
Vineland, NJ, USA). For plasma samples, a mixture of 400 µL filtered samples, 100 µL phosphate buffer
in D2O [27] (pH = 7.4), and 100 µL D2O containing 0.05% TSP were added into an NMR sample tube.
2.2.2. HR-MAS 1H NMR Spectroscopy
Frozen brain tissues were cut on a dry-ice bench to fit into 30-µL HR-MAS rotor inserts. D2O
containing 0.05% TSP was added into the inserts to provide a field-frequency lock for the NMR
spectrometer. The inserts were placed in 4-mm zirconium rotors for NMR analysis.
2.3. NMR Data Acquisition and Preprocessing
NMR spectra were recorded on a Bruker Avance III 600 MHz NMR spectrometer (Bruker BioSpin
Gmbh, Rheinstettten, Germany) equipped with a 5-mm 1H TXI probe for fluid samples and a 5-mm
HR-MAS probe for intact tissues operating at a 1H frequency of 600.13 MHz. A target temperature
of 298 K (CSF and plasma) and a relaxation delay of 5 s were applied. A total of 256 and 128 free
induction decays (FIDs) were acquired for the CSF and plasma samples, respectively. The acquisition
parameters included 32,768 data points, a spectral width of 7288 Hz, and an acquisition time of 2.25 s.
One-dimensional nuclear Overhauser effect spectroscopy (1D-NOESY) experiment with a single 90◦
pulse sequence and pre-saturation of the water resonance was conducted.
HR-MAS 1H NMR spectroscopy was carried out at 281 K with a spinning speed of 5000 Hz.
1D-NOESY experiment with pre-saturation was performed using a recycling delay of 3 s with
an acquisition time of 2.25 s. A spectral width of 7288 Hz was employed. In addition, the
Carr–Purcell–Meiboom–Gill (CPMG) pulse sequence with a T2 filter of 400 ms was applied. The
acquisition parameters included 128 scans, 32K data points, and a spectral width of 10,417 Hz using a
recycling delay of 3 s with an acquisition time of 1.57 s.
The spectra were processed with zero-filling prior to Fourier transformation. All spectra were
referenced to the TSP signal at 0.0 ppm. An experimental window function with a line-broadening
factor of 0.3 Hz was applied to all FIDs before Fourier transformation. The resulting spectra
were manually phase- and baseline-corrected by polynomial using the TopspinTM 3.0 software
(Bruker BioSpin, Gmbh, Rheinstetten, Germany). The NMR resonances were assigned based
on two-dimensional (2D) NMR spectroscopy, the Human Metabolome Database [28], existing
literature [29–33], and Chenomx NMR Suite 7.7 (Chenomx Inc, Edmonton, AB, Canada).
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2.4. Data Analysis
Matlab (version R2016b, MathWorks Inc., MA, United States) was used for data analysis and
visualization. Using the interval-correlation-shifting algorithm (icoshift) [34], the NMR spectra were
aligned by local shifting of a total number of 50 intervals and customized intervals for CSF, plasma
(with five missing samples from the total of 26 piglets, CON + TPN (n = 7), SE + TPN (n = 5), and SE
+ COL (n = 9)), and brain tissue data (with four missing samples from the total of 26 piglets, CON
+ TPN (n = 7), SE + TPN (n = 5), and SE + COL (n = 10)). Data were normalized to the intensity
of the TSP signal, and the brain data were further normalized to the total sum area under the peak.
The spectral region containing the residual water resonance (4.7–5.00 ppm) was excluded. Moreover,
unassigned peaks at 0.72 (t), 0.83 (t), and 0.95 (d) ppm were observed in the 1H NMR spectra of the
CSF samples. Inspection of the 2D 1H-13C spectra showed that the 1H resonances correlate to 13C
resonances at 11.83, 16.12, and 16.44 ppm, but assignment was not possible using available databases.
These unassigned spectral regions and regions containing signals from ethanol with resonances at
1.20 (t) and 3.60 (q) ppm and propylene glycol at 1.10 (d), 3.40 (dd), 3.50 (dd), and 3.90 (m) ppm were
excluded from the NMR spectra of the CSF samples prior to further analyses. High concentrations
of ethanol can be the result of contamination during sampling [35]. In HR-MAS brain data, only
the aliphatic part (1.3–4.5 ppm), excluding the ethanol and propylene glycol resonances, was used
for further analysis, as the aromatic part of the spectra contained few signals and therefore mostly
contributed to noise. CSF, plasma, and brain tissue NMR spectra were subdivided into 0.01 ppm
bins, reducing the spectra into 908, 953, and 322 separate variables, respectively. Moreover, unrelated
variation associated with a litter effect was removed by using the unbalanced ANOVA-simultaneous
component analysis (ASCA) model [36]. The data were mean-centered and pareto-scaled prior to
multivariate analysis. Principal component analysis (PCA) was performed to identify variations in
metabolite profiles among the samples. To determine whether the clinical data correlated with the
metabolic profiles, partial least squares (PLS) regressions were performed. The quality of the model
was evaluated by the goodness-of-fit parameter R2 and the predictive ability parameter Q2 using the
leave-one-out validation.
In addition, quantitative analysis of the 1H NMR spectra was performed by the integration of
peak areas using TopspinTM 3.0 software (Bruker BioSpin, Gmbh, Rheinstetten, Germany). For blood
and CSF, the identified metabolites were quantified based on the known internal TSP concentration.
The identified metabolites of brain were normalized to the total sum area under the peak prior to
analysis. A two-way ANOVA for an unbalanced design with the fixed effect of treatment, litter, and
treatment× litter was used to calculate the significance level of differences in metabolite concentrations
using the statistics and machine learning toolbox in Matlab. A Tukey–Kramer test with a significance
level of 0.05 was performed for all pairwise comparisons. Moreover, correlations between quantified
plasma metabolites and gene expression data were calculated and visualized by heat map plots. For
visualization, Pearson’s correlation coefficients and p-values for correlation between variables were
evaluated. Hierarchical cluster analysis (HCA) was initially applied to re-order the metabolites and
genes in the heat map according to similarities between the variables.
3. Results
The baseline characteristics birth weight (935, 1030, and 944 g) and male gender frequency (57,
44, and 40%) were not significantly different between CON + TPN, SE + TPN, and SE + COL groups
by one-way ANOVA and Fisher–Freeman–Halton exact test, respectively. CSF, blood plasma, and six
brain areas of interest from preterm newborn pigs were analyzed by 1H NMR and HR-MAS NMR
spectroscopy, and a total of 31, 36, and 26 metabolites were assigned in CSF, plasma, and brain tissues,
respectively (Figures 1 and 2).
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Figure 1. 1H NMR spectra (obtained at 600 MHz) of a control sample and the identified metabolites: 
(a) cerebrospinal fluid (CSF) and (b) plasma. Abbreviations: Ace: acetate; Ala: alanine; Bet: betaine; 
Cho: choline; Ci: citrate; Cn: creatinine; Cr: creatine; DMG: N,N-dimethylglycine; Et: ethanol; α-, β-
Glc: α-, β-glucose; Glu: glutamate; Gln: glutamine; Glyr: glycerol; Gly: glycine; Ileu: isoleucine; IPA: 
isopropanol; Lac: lactate; Leu: leucine; Lys: lysine; Met: methionine; m-I: myo-inositol; PG: propylene 
glycol; Pyr: pyruvate; Suc: succinate; Val: valine. 
 
Figure 2. High-resolution magic-angle spinning (HR-MAS) 1H NMR spectra (obtained at 600 MHz) 
of control brain samples and the identified metabolites: (a) cerebellum, (b) periventricular white 
matter, (c) striatum, (d) hypothalamus, (e) prefrontal cortex, and (f) midbrain. Abbreviations: Ala: 
alanine; ACh: acetylcholine; GABA: γ-aminobutyric acid; Cho: choline; Cn: creatinine; Cr: creatine; 
Et: ethanol; Glu: glutamate; Gln: glutamine; Lac: lactate; Met: methionine; m-I: myo-inositol; NAA: N-
acetylaspartate; PG: propylene glycol. 
Figure 1. 1H NMR spectra (obtained at 600 MHz) of a control sample and the identified metabolites:
(a) cerebrospinal fluid (CSF) and (b) plasma. Abbreviations: Ace: acetate; Ala: alanine; Bet: betaine;
Cho: choline; Ci: citrate; Cn: creatinine; Cr: creatine; DMG: N,N-dimethylglycine; Et: ethanol; α-,
β-Glc: α-, β-glucose; Glu: glutamate; Gln: glutamine; Glyr: glycerol; Gly: glycine; Ileu: isoleucine; IPA:
isopropanol; Lac: lactate; Leu: leucine; Lys: lysine; Met: methionine; m-I: myo-inositol; PG: propylene
glycol; Pyr: pyruvate; Suc: succinate; Val: valine.
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Figure 2. High-resolution agic-angle spinning ( R- S) 1 R spectra (obtained at 600 MHz) of
control brain samples and the identified metabolites: (a) cerebellum, (b) periventricular white matter, (c)
striatum, (d) hypothalamus, (e) prefrontal cortex, and (f) midbrain. Abbreviations: Ala: alanine; ACh:
acetylcholine; GABA: γ-ami obutyric acid; Cho: choline; Cn: creatinine; Cr: creatine; Et: ethanol; Glu:
glutamate; Gln: glutamine; Lac: lactate; Met: methionine; m-I: myo-inositol; NAA: N-acetylaspartate;
PG: propylene glycol.
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A PCA score plot of the CSF metabolome revealed a tendency for separation of the SE + TPN
group from the other two groups along the second principal component (PC2), while the SE + COL
and control samples were grouped along PC3 (Figure 3a,b). Elucidation of the loading plot showed
that separation of the SE + TPN group could be ascribed mainly to an increase in lactate, alanine, and
myo-inositol levels, and a decrease in the glucose level in the SE + TPN group.
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(c, ) plasma samples. CON + TPN (green diamond) represents the control group, SE + TPN (red circles)
represents the infected group by Staphylococcus epidermidis (SE), and SE + COL (blue squares) represents
the colostrum (COL) supplementation group. In the loading plots: Ace: acetate; Ala: alanine; Cr:
creatine; Glc: glucose; lu: glutamate; Gly: glycine; Lac: lactate; Leu: leucine; Met: methionine; m-I:
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A two-way ANOVA was calculated for metabolites contributing to the grouping in the PCA score
plots, which revealed significant differences (p < 0.05) among treatment groups for lactate levels with a
higher concentration in the SE + TPN group and a reduced level after COLsupplementation (Table 1).
The litter and treatment × litter p-values can also be found in Table S1 (Supplementary Materials).
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Table 1. Results of two-way ANOVA calculated for metabolites altered under bloodstream infection
(BSI) and quantitated by 1H NMR spectroscopy. The metabolites included were derived from PCA.
Metabolite
Mean± SD Treatment
p-ValueCON + TPN SE + TPN SE + COL
Plasma
Lactate 1.46 ± 0.52 a 6.00 ± 0.63 b 1.32 ± 0.46 a <0.001
Alanine 0.33 ± 0.05 ab 0.43 ± 0.06 b 0.22 ± 0.04 a 0.046
Succinate/pyruvate 0.02 ± 0.01 a 0.08 ± 0.01 b 0.01 ± 0.01 a 0.001
Choline 0.03 ± 0.01 a 0.06 ± 0.01 b 0.04 ± 0.00 ab 0.021
Glutamate 1.15 ± 0.16 a 1.05 ± 0.19 a 1.00 ± 0.14 a N.S. *
myo-Inositol 8.35 ± 1.26 a 8.66 ± 1.51 a 8.56 ± 1.11 a N.S.
Methionine 0.57 ± 0.06 b 0.58 ± 0.07 b 0.24 ± 0.05 a 0.001
Valine 0.20 ± 0.03 a 0.26 ± 0.03 a 0.37 ± 0.03 b 0.001
Leucine 0.02 ± 0.01 a 0.03 ± 0.01 a 0.07 ± 0.00 b <0.001
CSF
Lactate 0.34 ± 0.09 a 0.62 ± 0.08 b 0.30 ± 0.08 a 0.021
Alanine 0.01 ± 0.00 a 0.02 ± 0.00 a 0.01 ± 0.00 a 0.066
Choline 0.004 ± 0.001 a 0.004 ± 0.001 a 0.004 ± 0.001 a N.S.
Succinate/pyruvate 0.03 ± 0.00 a 0.02 ± 0.00 a 0.02 ± 0.00 a 0.064
Glutamate 0.13 ± 0.01 a 0.1 ± 0.01 a 0.09 ± 0.01 a N.S.
myo-Inositol 0.56 ± 0.06 a 0.69 ± 0.05 a 0.67 ± 0.05 a N.S.
Methionine 0.004 ± 0.00 b 0.003 ± 0.00 b 0.001 ± 0.00 a <0.001
PVMW
Choline 4.83 ± 2.06 a 0.85 ± 2.46 a 8.54 ± 1.74 a 0.060
Lactate 8.44 ± 3.09 a 2.10 ± 3.70 a 12.66 ± 2.62 a 0.095
N-acetylaspartate 8.09 ± 3.10 a 1.84 ± 3.70 a 12.84 ± 2.62 a 0.079
Creatine 7.45 ± 3.34 a 1.67 ± 3.99 a 13.79 ± 2.82 a 0.066
Values are represented as means ± standard deviation (SD). For blood and CSF, identified metabolites were
quantified based on the known internal sodium trimethylsilyl-[2,2,3,3-2H4]-1-propionate (TSP) concentration and
are expressed in mM. Brain metabolites were normalized to the total sum area under the peak prior to ANOVA
analysis. The number of samples for each treatment group is as follows—for CSF samples: CON + TPN (n = 7),
SE + TPN (n = 9), and SE + COL (n = 10); for plasma samples: CON + TPN (n = 7), SE + TPN (n = 5), and SE + COL
(n = 9); and for brain samples: CON + TPN (n = 7), SE + TPN (n = 5), and SE + COL (n = 10). PVMW: periventricular
white matter. * N.S. non-significant (p > 0.05). However, p-values below 0.1 are represented. Different subscript
letters indicate statistically significant pair-wise differences of treatment.
Results from the plasma metabolome showed the same trend as metabolite perturbations
identified in CSF, and the PCA score plot revealed a strong separation between treatment groups
(Figure 3c,d). The SE + TPN group had higher levels of plasma lactate, alanine, and succinate/pyruvate
(all p < 0.05, Figure 3d and Table 1) compared with CON + TPN and SE + COL. Furthermore, PCA
loadings revealed that resonances from glucose and myo-inositol exhibited decreased and increased
intensities in SE + TPN piglets, respectively, and contributed to the group separation, although not
reaching a statistically significant difference between groups in the ANOVA analysis, possibly due
to the small samples size and the small nature of the differences (Table 1). In addition, the SE + COL
group was separated from the CON + TPN group along PC3 with lower levels of plasma methionine
and higher levels of leucine and valine in SE + COL (all p < 0.05, Figure 3b and Table 1), possibly
due to an absorption and metabolism of colostrum proteins. A PLS model with three components
(R2 = 0.89, Q2 = 0.55, and root mean square prediction error (RMSPE) = 1.6 × 10−3) indicated that
the NMR spectra of plasma had a good fit and prediction ability for the cerebral microglia density
(Figure 4a). From the PLS weights, it could be observed that lactate and myo-inositol were the most
important variables to build a quantitative relationship between the NMR data and cerebral microglia
density (Figure 4b).
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orrelation analysis between plasma metabolites and hippocampus gene expression data revealed
a positive correlation of expression levels of some genes ( ostly clustered together and presented as
colored HCA on the right-hand side of the heat map), while genes such as HK2, TLR4, CCL3, SELE,
and TF as well as COX-2 (also known as PTGS2), ICAM1 and VCAM1 were significantly correlated
with lactate, succinate, and choline (Figure 5). These genes were upregulated in the sepsis condition,
while the expression levels of COX-2 and SELE were reduced after colostrum supplementation [25].
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For etabolo es of various brain parts, a clear separation of the treat ent groups could not be
observed in the PCA score plots (data not sho n). er, a ong the dif erent brain parts, P
sho ed a tendency toward the clustering of treatment groups and choline-containing metabolites
contribute ostly to the variation in the data (Figure S1 in Sup lementary Materials). Two- ay
ANOVA of the metabolites responsible for the variation in the data revealed that the intensity of
choline was different (p = 0. 6) among treatment groups with a lower level in the SE + TPN group and
an increased level after COL supplementatio (Table 1). On the other hand, the opposite trend could
be observed in the plasma metabolome wher choline ad a significantly higher conc ntratio in he
SE + TPN samples (p < 0.05).
4. iscussion
In the present study, we examined the perturbations in systemic and cerebral metabolism and the
impact of a bioactive milk diet, bovine colostrum, during BSI in a preterm pig model. After 24 h of
SE administration, NMR-based metabolomics revealed significant changes in the plasma level of key
intermediates involved in energy metabolism, such as lactate, alanine, and succinate as well as specific
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amino acids. These results are in agreement with other studies showing that sepsis causes impaired
cerebral energy metabolism and disturbances in the tricarboxylic acid (TCA) cycle [37,38]. Importantly,
this metabolic alteration was mirrored in the CSF in this early phase of infection, and lactate, which
is one of the most important biomarkers for impaired energy metabolism, increased significantly in
infected animals and was modulated by early feeding with bovine colostrum.
Alterations in lactate levels revealed effects on energy metabolism associated with an enhanced
glycolysis during BSI. This enhanced glycolysis appears to be linked with an upregulation of
hypoxia-regulated genes in the hippocampus, when aerobic energy metabolism is inhibited by
decreased oxygen availability and a high demand of energy during infection [39]. The decreased
glucose level during BSI indicates either an increased glucose consumption by circulating bacteria or
an increased cellular uptake and conversion to glucose-6-phosphate (G6P) [39]. Due to limited oxygen
availability, the electron transport chain stalls, electron acceptors, cannot be regenerated, causing
succinate levels to increase. To increase the production of adenosine triphosphate, the main source of
cellular energy, glycolysis is enhanced, leading to increased levels of pyruvate, which is converted to
either lactate to regenerate glycolytic electron acceptors or to alanine, a gluconeogenic substrate. An
overview of the altered metabolic pathways is illustrated in Figure 6.
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Figure 6. Schematic representation of altered etabolites during systemic infla atory response
under BSI condition. Blood delivers the glucose to tissues, where it reaches cells through diffusion and
by glucose transporters. Glucose is converted to G6P and then pyruvate through glycolysis, leading to
lactate accumulation as well as an elevated tricarboxylic acid cycle. The altered metabolites are shown
in yellow. Red and blue arrows represent SE + TPN and SE + COL, respectively, and denote higher and
lower levels of the respective metabolites compared to controls.
A significantly increased level of plasma choline was observed in infected piglets, which was
attenuated after colostrum supplementation. On the other hand, infected piglets exhibited a lower
level of choline in the brain. An increase in the plasma level of choline, which is a metabolite that is
fundamental for the integrity of cellular membranes, lipid metabolism, and the development of the
brain, can possibly be associated with the severity of the cerebral damage. Such increases in the plasma
of animals with sepsis [40] as well as in the umbilical cord serum of neonatal asphyxia [41] have been
reported and explained by an enhanced lipolysis and dysfunctional process of lipid metabolism [42].
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On the contrary, a decreased level of choline species has been reported in the plasma of sepsis patients
when compared with healthy controls [43]. However, the metabolite responses related to an enhanced
energy metabolism might be different from other age groups as the studied group was encountering
infection for the first time and lacked proper immune responses [44].
Besides the metabolic perturbations, hippocampus gene expression has been proposed as
informative for an inflammatory condition [45]. Several studies have shown the gene expression plays
an important role in regulating metabolism in response to perturbations [46,47]. A cell can be adapted
to the changing environment by alteration in the expression of genes. Investigating the association
between the gene expression and metabolite shifts is particularly relevant as the metabolome can
reflect responses to environmental perturbation and the metabolic phenotype [46]. Linking the set of
the expressed genes to metabolism, the plasma metabolome was used for a correlation analysis, since
plasma can act as an internal indicator of the changes while covering a higher number of metabolites
with better representation of the BSI condition as compared to other biofluids. Investigating the
network of metabolite and gene interactions illustrated expression changes related to the metabolite
pathway perturbations. Even though some correlations did not reach the significance level (p < 0.05),
the establishment of a correlation pattern suggested that a proportion of the metabolite adaptation is
transcriptionally regulated. A change in cerebral energy metabolism during BSI coincided with an
upregulation of the glucose transporter 3 (GLUT3) and the rate-limiting glycolytic enzyme hexokinase
2 (HK2), which phosphorylates glucose to produce G6P. TLR4 activation, which is responsible for
innate immune signaling and pro-inflammatory responses, shifts the energy metabolism of circulating
immune cells from mitochondrial oxidative phosphorylation to glycolysis [48,49]. On the other
hand, it has been reported that an increase in succinate activates the hypoxia inducible factor-1a and
consequently promotes the inflammatory gene expression [50].
Although a few studies have examined the effect of bovine colostrum on cytokine
production [51,52], investigations on the specific metabolic impact of colostrum intervention in preterm
infants are lacking. Anti-inflammatory and anti-microbial proteins and peptides in colostrum might
play an important role in preventing BSI, by mechanisms such as limiting bacterial overgrowth and
translocation in the gut [21]. Bovine lactoferrin intervention indicated the possibility of the prevention
of the late-onset sepsisin preterm infants [53]. However, it has been reported that casein is less
digestible than whey protein due to its easy coagulation in the stomach [54]. Notably, the present study
revealed that colostrum supplementation attenuated the BSI-induced increases in lactate, alanine,
and succinate levels in plasma with almost similar trends in CSF. This is in line with published data
from the same animal experiment, showing reduced blood oxygen partial pressure and saturation
during SE infection, which were prevented by colostrum supplementation [25]. Moreover, previously
documented improvements in blood and CSF bacterial clearance after colostrum supplementation
suggest that changes to immune activation and function may underlie the metabolic changes seen
here [25].
In addition to the effects on metabolic intermediates involved in energy metabolism, the present
study also identified significant effects of colostrum supplementation on plasma levels of methionine,
valine, and leucine as well as the level of methionine in CSF. These effects may reflect direct differences
in amino acid quantity and absorption between bovine colostrum and the parenteral formulation, and
it remains unknown if changes in the levels of these amino acids exert a biological effect.
Effects of BSI on myo-inositol metabolism were also identified. Myo-inositol is synthesized
from glucose via G6P (the first product of glycolysis) [55] (Figure 6). The concentration of
myo-inositol increases with glial proliferation or the increase of cell size, both of which occur
during inflammation [56]. Of note, we previously showed that SE infection increases both cerebral
microglia/macrophage numbers and cell size [25]. In this study, a correlation between the plasma
metabolome, especially lactate and myo-inositol, and cerebral microglia density was observed by a PLS
regression model (Figure 4). Free myo-inositol is present in all human tissues, but its concentration is
highest in newborns, suggesting an important role in the neonatal period [57], wherein serum levels
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have also been found to be linked with birth weight [58]. Indeed, myo-inositol has beneficial effects on
pulmonary function in preterm infants with respiratory distress [59]. We speculate that myo-inositol
may act to improve pulmonary function during sepsis.
The present study used a preterm piglet model, which has formerly been shown to be a clinically
relevant BSI model [16]. This piglet model has a fundamental advantage as it enables multiple
samplings from different organs and tissues that would not be available in a human setup. However,
the model also has its limitations. Our study revealed a considerable variation in the metabolome of the
piglets even within the same treatment groups. This large inter-individual variation reflects differences
in the metabolic phenotype among the piglets as well as variations in the response to the applied
S. epidermis infection. The presence of this variation influences the ability to identify and establish
generic metabolic markers. Further studies targeted at identifying the phenotypic characteristics of the
piglet model are warranted.
5. Conclusions
Applying metabolomics analyses on a piglet model of BSI revealed associations between infection
and metabolic changes related to the glycolysis and tricarboxylic acid cycle. In addition, the plasma
and CSF level of myo-inositol was affected by BSI, which may have an impact on the lung maturation of
preterm infants and pulmonary function during sepsis. Finally, the study revealed that hypoxia-related
changes in systemic and cerebral energy metabolism were attenuated by oral COL supplementation,
suggesting a protective role on the regulation of inflammatory responses.
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